+73.4%
CURE vs SPY
+58.8%
+14.6%
-51.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -3.6% | +2.7% | +3.7% |
| 7D | -18.3% | -8.6% | -9.8% | -8.3% |
| 30D | -5.3% | -10.8% | +5.5% | +9.8% |
| 3M | +3.7% | -9.3% | +13.0% | +17.7% |
| 6M | +60.9% | -6.5% | +67.4% | +73.5% |
| YTD | +31.1% | +1.9% | +29.2% | +24.8% |
| 1Y | +39.5% | +6.9% | +32.6% | +24.4% |
| 3Y | +73.4% | +57.5% | +15.9% | -16.6% |
| All | +73.4% | +58.8% | +14.6% | -16.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SPY.
Daily Out/Under-Performance
Portfolio return minus SPY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling